152 related articles for article (PubMed ID: 8179072)
41. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
[TBL] [Abstract][Full Text] [Related]
42. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
Stefansson IM; Salvesen HB; Immervoll H; Akslen LA
Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
[TBL] [Abstract][Full Text] [Related]
43. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
[TBL] [Abstract][Full Text] [Related]
44. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
[TBL] [Abstract][Full Text] [Related]
45. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.
Desrosiers L; Fadare O; Xiao ZF; Dresser K; Wang SA
Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471
[TBL] [Abstract][Full Text] [Related]
46. The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma.
Hanley KZ; Dustin SM; Stoler MH; Atkins KA
Int J Gynecol Pathol; 2010 Sep; 29(5):445-51. PubMed ID: 20736770
[TBL] [Abstract][Full Text] [Related]
47. [Clinical studies of 145 cases of endometrial carcinoma--analysis of prognostic factors, especially pathological types].
Fukuma K; Tohya T; Souda Y; Fuzisaki S; Maeyama M; Mimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1508-14. PubMed ID: 3772201
[TBL] [Abstract][Full Text] [Related]
48. New aspects of endometrial carcinoma.
Silverberg SG
Clin Obstet Gynaecol; 1984 Apr; 11(1):189-208. PubMed ID: 6370532
[TBL] [Abstract][Full Text] [Related]
49. Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.
Kallakury BV; Ambros RA; Hayner-Buchan AM; Sheehan CE; Malfetano JH; Ross JS
Int J Gynecol Pathol; 1998 Oct; 17(4):320-6. PubMed ID: 9785132
[TBL] [Abstract][Full Text] [Related]
50. Pathological findings in early-stage endometrial cancer.
Zehavi S; Schneider D; Bukovsky I; Halperin R
Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors relating to survival in uterine endometrioid carcinoma.
Hirai M; Hirono M; Oosaki T; Hayashi Y; Yoshihara T; Matsuzaki O
Int J Gynaecol Obstet; 1999 Aug; 66(2):155-62. PubMed ID: 10468339
[TBL] [Abstract][Full Text] [Related]
52. Evolution of a trophoblastic tumor from an endometrioid carcinoma--a morphological and molecular analysis.
Olson MT; Gocke CD; Giuntoli RL; Shih IeM
Int J Gynecol Pathol; 2011 Mar; 30(2):117-20. PubMed ID: 21293290
[TBL] [Abstract][Full Text] [Related]
53. Juxtatumoral stromal reactions in uterine endometrioid adenocarcinoma and their prognostic significance.
Wei S; Conner MG; Zhang K; Siegal GP; Novak L
Int J Gynecol Pathol; 2010 Nov; 29(6):562-7. PubMed ID: 20881855
[TBL] [Abstract][Full Text] [Related]
54. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
Bell KA; Kurman RJ
Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848
[TBL] [Abstract][Full Text] [Related]
55. Papillary Endometrioid Carcinoma of Intermediate Grade with Infiltration in a Leiomyoma.
Shopov S
Folia Med (Plovdiv); 2020 Mar; 62(1):190-194. PubMed ID: 32337888
[TBL] [Abstract][Full Text] [Related]
56. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.
Sherman ME; Bitterman P; Rosenshein NB; Delgado G; Kurman RJ
Am J Surg Pathol; 1992 Jun; 16(6):600-10. PubMed ID: 1599038
[TBL] [Abstract][Full Text] [Related]
57. [When cancer of the endometrium is not a good cancer].
Deligdisch L
Rev Fr Gynecol Obstet; 1990 Oct; 85(10):513-6. PubMed ID: 2263829
[TBL] [Abstract][Full Text] [Related]
58. Endometrioid endometrial adenocarcinoma with psammoma bodies.
Parkash V; Carcangiu ML
Am J Surg Pathol; 1997 Apr; 21(4):399-406. PubMed ID: 9130986
[TBL] [Abstract][Full Text] [Related]
59. [Pathologic diagnosis of endometrial carcinoma in curettage specimens in women under forty years of age].
Wang MQ; Zhang QH; Guo LL; Cai YR; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):262-5. PubMed ID: 16181545
[TBL] [Abstract][Full Text] [Related]
60. Morphometric analysis of endometrial adenocarcinoma: 1. Does architectural dedifferentiation accompany deep invasion by endometrial adenocarcinoma?
Zaino RJ; Laskaris A; Whitney C; Sharkey FE
Int J Gynecol Pathol; 1987; 6(1):12-9. PubMed ID: 3570628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
